OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $688,000 | +67.4% | 173,200 | +67.7% | 0.01% | +80.0% |
| Q4 2018 | $411,000 | -42.2% | 103,300 | 0.0% | 0.01% | -28.6% |
| Q3 2018 | $711,000 | +2.0% | 103,300 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $697,000 | +3.7% | 103,300 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $672,000 | +46.1% | 103,300 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $460,000 | -27.9% | 103,300 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $638,000 | -31.2% | 103,300 | +3.3% | 0.01% | -36.4% |
| Q2 2017 | $927,000 | -0.1% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $928,000 | +10.9% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $837,000 | +21.8% | 100,000 | 0.0% | 0.01% | +10.0% |
| Q3 2016 | $687,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |